Evidence map›Paper›PMID 30430399›Full record

ArticleInfection2019

Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization.

Elias Fares, Cindy B McCloskey, Andres Gutierrez, Michael Princiotta, Linda J Salinas, Douglas A Drevets

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. ReprogrammingmBio · 2026
    Article
  2. Article
  3. Infection and immunity · 2025
    Article
  4. First case of aorto-bi-iliac endograft thrombotic infection byExperimental and therapeutic medicine · 2022
    Article
  5. The Viable But Non-Culturable State ofFrontiers in cellular and infection microbiology · 2022
    Review
  6. RecombinantFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Safety of a NovelFrontiers in cellular and infection microbiology · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Elias FaresSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, Suite 7300, Oklahoma City, OK, 73104, USA.
Cindy B McCloskeyDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Andres GutierrezAdvaxis, Inc, Princeton, NJ, USA.
Michael PrinciottaAdvaxis, Inc, Princeton, NJ, USA.
Linda J SalinasSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, Suite 7300, Oklahoma City, OK, 73104, USA.
Douglas A DrevetsSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, Suite 7300, Oklahoma City, OK, 73104, USA. douglas-drevets@ouhsc.edu.
Advaxis (United States) · USUniversity of Oklahoma Health Sciences Center · USErie VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundListeria monocytogenes is a food-borne, facultative intracellular bacterium that causes severe diseases such as sepsis and meningoencephalitis in immunocompromised hosts. Because it stimulates robust T-lymphocyte-mediated responses, attenuated L. monocytogenes are candidate vaccine vectors for tumor immunotherapy. CASE: We report a case of bacteremia caused by vaccine strain L. monocytogenes (Axalimogene filolisbac) occurring 31 months after immunization against human papilloma virus (HPV) associated cervical cancer.

conclusionReceipt of a L. monocytogenes-based vaccine is a novel risk factor for delayed L. monocytogenes bacteremia.

Indexed as

BacteremiaBacterial VaccinesFatal OutcomeFemaleHumansImmunizationListeria monocytogenesListeriosisMiddle AgedOklahomaPapillomavirus InfectionsTime FactorsUterine Cervical NeoplasmsBacterial VaccinesImmunotherapyLive vaccineRecurrent listeriosis. Listeria vaccine

Identifiers

PMID30430399
OpenAlexW2901620322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.